Michael Penn is looking to make more of a deeper difference in his return to the Gladstone.
Penn, who spent the past eight years as a product and business development manager at biotech powerhouse Genentech Inc. in South San Francisco, was hired last month as the first vice president for strategy at the Gladstone Institutes.
His duties take in development, fundraising and communications for the San Francisco institute, which has units zeroed in on cardiovascular research, neurology and virology and immunology.
No comments:
Post a Comment